Apheresis Technology for Prevention and Regression of Atherosclerosis: An Overview-Reference-Cited by-同舟云学术

Apheresis Technology for Prevention and Regression of Atherosclerosis: An Overview

Published:1997-08 Issue:3 Volume:1 Page:233-241
ISSN:1091-6660
Container-title:Therapeutic Apheresis
language:en
Short-container-title:

Author:

Yamamoto Akira,Kawaguchi Akito,Harada-Shiba Mariko,Tsushima Motoo,Kojima Shun-ichi

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.1997.tb00144.x/fullpdf

Reference60 articles.

1. Cholesterol and mortality. 30 years follow up from the Framingham Study;Anderson;JAMA,1987

2. Neaton JD for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded‘? Finding in 356,222 primary screenees of the multiple risk factors intervention trial;Stamler;JAMA,1986

3. Regression of atherosclerosis in humans by lowering serum cholesterol (Review);Yamamoto;Arherosclerosis,1901

4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group.;Lancet,1994

5. for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hyper-cholesterolemia;Shepherd;N Engl J Med,1995

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apheresis Methods in Hyperlipidemias;Dyslipidemias in Kidney Disease;2014

2. The lower the better: Target values after LDL-Apheresis and semi-selective LDL-elimination therapies;Transfusion and Apheresis Science;2013-04

3. LDL-Apheresis: Technical and Clinical Aspects;The Scientific World Journal;2012

4. Adverse Events in Therapeutic Apheresis: A Single Center Survey of Various Therapies;Therapeutic Apheresis and Dialysis;2010-11-30

5. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy;Atherosclerosis;2006-05